Belinda Gier

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
    Belinda Gier
    Larry L Hillblom Islet Research Center, University of California Los Angeles UCLA, David Geffen School of Medicine, Los Angeles, California, USA
    Diabetes 61:1250-62. 2012
  2. ncbi Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
    Michael Elashoff
    Larry L Hillblom Islet Research Center at David Geffen School of Medicine and Department of Biomathematics, University of California, Los Angeles, California 90095 7073, USA
    Gastroenterology 141:150-6. 2011
  3. ncbi Glucagon like peptide-1 receptor expression in the human thyroid gland
    Belinda Gier
    Larry L Hillblom Islet Research Center, David Geffen School of Medicine at the University of California, Los Angeles, 10833 Le Conte Avenue 72 228 CHS, Los Angeles, California 90095 6904, USA
    J Clin Endocrinol Metab 97:121-31. 2012

Collaborators

Detail Information

Publications3

  1. ncbi Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
    Belinda Gier
    Larry L Hillblom Islet Research Center, University of California Los Angeles UCLA, David Geffen School of Medicine, Los Angeles, California, USA
    Diabetes 61:1250-62. 2012
    ..These data reveal that GLP-1 mimetic therapy may induce focal proliferation in the exocrine pancreas and, in the context of exocrine dysplasia, may accelerate formation of neoplastic PanIN lesions and exacerbate chronic pancreatitis...
  2. ncbi Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
    Michael Elashoff
    Larry L Hillblom Islet Research Center at David Geffen School of Medicine and Department of Biomathematics, University of California, Los Angeles, California 90095 7073, USA
    Gastroenterology 141:150-6. 2011
    ..There are also concerns that dipeptidyl peptidase-4 inhibitors could cause cancer, given their effects on immune function...
  3. ncbi Glucagon like peptide-1 receptor expression in the human thyroid gland
    Belinda Gier
    Larry L Hillblom Islet Research Center, David Geffen School of Medicine at the University of California, Los Angeles, 10833 Le Conte Avenue 72 228 CHS, Los Angeles, California 90095 6904, USA
    J Clin Endocrinol Metab 97:121-31. 2012
    ..We sought to establish whether C cells in human medullary thyroid carcinoma, C cell hyperplasia, and normal human thyroid express the GLP-1 receptor...